Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Up 59.8% in December

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 272,100 shares, an increase of 59.8% from the November 30th total of 170,300 shares. Based on an average daily trading volume, of 283,400 shares, the days-to-cover ratio is currently 1.0 days. Approximately 6.3% of the company’s stock are sold short.

Silo Pharma Stock Down 1.2 %

Shares of NASDAQ:SILO opened at $0.94 on Monday. Silo Pharma has a fifty-two week low of $0.77 and a fifty-two week high of $4.50. The firm’s 50 day moving average price is $1.02 and its 200 day moving average price is $1.21.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.